Have you or a loved one been diagnosed with Idiopathic Pulmonary Fibrosis (IPF)? If so, we would like to know your views on IPF care in the UK. In July 2015, Action for Pulmonary Fibrosis (APF) conducted its first patient survey to assess the extent to which the NICE guidelines […]
ILD highlights from the ERS 2017 Congress, 9th September – 13th September in Milan, Italy. The presentation covers progress, new clinical trails, research updates and insights from experts in the field.
Roche’s new Esbriet tablet formulation has been approved for testing in Europe. The attached media release covers further details on the approval.
Help raise funds for IPF research & care. Learn more about how you can organise your own fundraising events to support ILD.
Organise your own tea or coffee catchup! Share experiences, advice or tips for living with IPF.
Action for Pulmonary Fibrosis is working on a project to bring together a group of 20 patients to join an impromptu choir to raise awareness of IPF, if you would like to take part please see further details below, all expenses accommodation and travel will be covered.